[1] 金玉楠, 卢晓梅, 张海鹏, JIN Yu-nan, LU Xiao-mei, ZHANG Hai-peng. 灯盏花素对脑缺血再灌注小鼠脑组织病理变化的影响 [J]. 锦州医学院学报 2006.doi:10.3969/j.issn.1674-0424.2006.04.015
[2] 陈彪, 马秋兰. 阿尔茨海默病病因学研究进展及治疗展望 [J]. 中华神经科杂志 2003.doi:10.3760/j.issn:1006-7876.2003.02.031
[3] 彭海东, 涂晋文. 灯盏花素对大鼠脑缺血再灌注后迟发性神经元死亡的保护作用 [J]. 湖南中医学院学报 2006.doi:10.3969/j.issn.1674-070X.2006.01.013
[4] 尹明华, 徐晓虹, 李怡佳, YIN Ming-hua, XU Xiao-hong, LI Yi-jia. 灯盏花素对缺血再灌注小鼠脑细胞凋亡的保护作用 [J]. 中国药学杂志 2008.doi:10.3321/j.issn:1001-2494.2008.03.008
[5] 徐晓虹, 陈瑜, 郑筱祥, XU Xiao-hong, CHEN Yu, ZHENG Xiao-xiang. 灯盏花素对谷氨酸诱导大鼠海马神经细胞毒性的保护作用 [J]. 药学学报 2007.doi:10.3321/j.issn:0513-4870.2007.06.003
[6] 彭海东, 涂晋文, 田俊. 灯盏花素对大鼠脑缺血再灌注后脑含水量和脑组织钙含量的影响 [J]. 湖北中医学院学报 2002.doi:10.3969/j.issn.1008-987X.2002.03.009
[7] 周乐全, 康亚丽, 丁胜元, 闫福曼, 李小英, ZHOU Lequan, KANG Yai, DING Shengyuan, YAN Fuman, LI Xiaoying. 灯盏花素对大鼠全脑缺血再灌注后海马神经元L型钙通道的影响 [J]. 中药新药与临床药理 2006.doi:10.3321/j.issn:1003-9783.2006.06.009
[8] 周乐全, 康亚丽, 闫福曼, 丁胜元, 李小英, ZHOU Le-quan, KANG Ya-li, YAN Fu-man, Ding Sheng-yuan, Li Xiao-ying. 大鼠全脑缺血前注射灯盏花素对再灌后海马神经元内钙离子浓度的影响 [J]. 广东医学院学报 2007.doi:10.3969/j.issn.1005-4057.2007.01.003
[9] 薛峥, 王雪松, 阮旭中. 灯盏花素对大鼠脑缺血后细胞间粘附分子-1及其mRNA表达的影响 [J]. 中国病理生理杂志 2004.doi:10.3321/j.issn:1000-4718.2004.12.029
[10] 吴燕, 杨艳. 灯盏细辛注射液治疗活动性类风湿关节炎疗效观察 [J]. 广东医学 2003.doi:10.3969/j.issn.1001-9448.2003.12.054
[11] 翁锦龙, 阮甦. 灯盏细辛注射液治疗老年高脂血症36例疗效观察 [J]. 广东医学 2004.doi:10.3969/j.issn.1001-9448.2004.02.048
[12] Ikeda T, Mishima K, Yoshikawa T, Iwasaki K, Fujiwara M, Xia YX, Ikenoue T. [J]. Behavioural Brain Research: An International Journal 2001.
[13] 帅杰, 董为伟. PKC抑制剂灯盏花素对缺血/再灌流脑损害的作用研究 [J]. 1998.
[14] 杨群华, 唐省三. 灯盏花素对大鼠脑缺血-再灌注后脑内NF-κB表达的抑制作用 [J]. 中药材 2010.
[15] 陈小夏, 何冰, 杜淇璋. 灯盏花素对缺血再灌注大鼠组织ATPase活性的保护作用 [J]. 中药新药与临床药理 1998, 9(04).
[16] HONG Hao, LIU Guoqing. Protection against hydrogen peroxide-induced cytotoxitity in PC12 cells by scutellarin [J]. Life Sciences 2004, 74(24).
[17] Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC, Landfield PW. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. [J]. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2003, 9(9).
[18] MCGEER P L, MCGEER E G. Local neuroinflammation and the progression of Alzheimer's disease [J]. Journal of Neurovirology 2002, 8(06).
[19] HE Wei, LIU Yiming, CHEN Hui. Effects of breviscapine on brain edema and neutrophil inflitration induced by focal cerebral ischemia and reperfusion in rats [J]. Chinese Journal of Pharmacology and Toxicology 2004, 18(03).
[20] WOLOZIN B, KELLMAN W, RUOSSEAU P. Decreased prevalence of Ahheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme a reductase inhibitors [J]. Archives of Neurology 2000, 57(10).
[21] Zacco A, Togo J, Spence K, Ellis A, Lloyd D, Furlong S, Piser T. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. [J]. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2003, 35(35).
[22] Puglielli L, Tanzi RE, Kovacs DM. Alzheimer's disease: the cholesterol connection. [J]. Nature neuroscience 2003, 4(4).
[23] KORCZYN A D, VAKHAPOVA V. The prevention of the dementia epidemic [J]. Journal of the Neurological Sciences 2007, 257(1-2). |
